Consent for treatment is a key element of care, in terms of the quality of clinical decision-making, experiences of patient-centred care, and organisational medico-legal risk.
Following recent landmark cases (Montgomery 2015, Thefaut vs Johnston 2017, Paterson Inquiry 2020), informed consent practices have been brought to the forefront, with new standards needing to be met around personalisation and documentation of the consent process. New guidance requires adequate time to be allowed for consideration of consent and the necessity to provide information in lay language addressed directly to the patient.
In parallel, significant evidence has been demonstrated of the benefits of increased patient engagement in shared decision-making and the consent process, leading to better, often more conservative, decisions.
The current paper consent process has been demonstrated to be associated with significant errors and inappropriate variation in practice, contributing to both medico-legal risk, system inefficiencies, and poor patient experiences. A recent BJS paper highlights many of these issues.
How does it work?
This 3 minute video is a demonstration of the Concentric digital consent application:
Digital transformation of your consent process with Concentric will lead to the following:
- Reduced consent form errors, omissions and medicolegal risk, with improved documentation of the consent process.
- Remote consent functionality to reduce need for physical consent consultation.
- Improved patient experience of decision-making process and understanding of decisions.
- Release of clinical time through reduced administrative time.
- Improved operational efficiency such as reduced day-of-surgery cancellations and delays.
- Reduced paper use, both consent forms and patient information leaflets.
An example benefits realisation table, including benefit description, outcome and measurement appropriate for use in a business case can be found here.